ScholarIQanswers from OpenAlex

The evolution of lung cancer and impact of subclonal selection in TRACERx

PaperCitations, authors & open-access status

The evolution of lung cancer and impact of subclonal selection in TRACERx is a paper indexed in ScholarIQ from OpenAlex.

How many citations does The evolution of lung cancer and impact of subclonal selection in TRACERx have?

ScholarIQcitation count

The evolution of lung cancer and impact of subclonal selection in TRACERx has 319 citations in the OpenAlex counts ScholarIQ stores.

When was The evolution of lung cancer and impact of subclonal selection in TRACERx published?

ScholarIQyear

The evolution of lung cancer and impact of subclonal selection in TRACERx has 2023 year in the ScholarIQ index.

What is the open-access status of The evolution of lung cancer and impact of subclonal selection in TRACERx?

ScholarIQoa status

The evolution of lung cancer and impact of subclonal selection in TRACERx has hybrid oa status in the ScholarIQ index.

What is the DOI of The evolution of lung cancer and impact of subclonal selection in TRACERx?

ScholarIQdoi

The DOI for The evolution of lung cancer and impact of subclonal selection in TRACERx is on the source record.

What is the PMID of The evolution of lung cancer and impact of subclonal selection in TRACERx?

ScholarIQpmid

The PMID for The evolution of lung cancer and impact of subclonal selection in TRACERx is on the source record.

What is the OpenAlex record for The evolution of lung cancer and impact of subclonal selection in TRACERx?

ScholarIQopenalex

The OpenAlex for The evolution of lung cancer and impact of subclonal selection in TRACERx is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial